In vitro and in vivo immunomodulatory properties of octyl-β-d-galactofuranoside during Leishmania donovani infection

BACKGROUND: The chemotherapeutic arsenal available to treat visceral leishmaniasis is currently limited, in view of many drawbacks such as high cost, toxicity or emerging resistance. New therapeutic strategies are particularly needed to improve the management and the outcome in immunosuppressed pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Guegan, Hélène, Ory, Kevin, Belaz, Sorya, Jan, Aurélien, Dion, Sarah, Legentil, Laurent, Manuel, Christelle, Lemiègre, Loïc, Vives, Thomas, Ferrières, Vincent, Gangneux, Jean-Pierre, Robert-Gangneux, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929453/
https://www.ncbi.nlm.nih.gov/pubmed/31870416
http://dx.doi.org/10.1186/s13071-019-3858-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929453/
https://www.ncbi.nlm.nih.gov/pubmed/31870416
http://dx.doi.org/10.1186/s13071-019-3858-0

Ejemplares similares